Western blot analysis displayed that CEA expression was not affected by onalespib treatment in any of the assessed colorectal cancer cell lines, while known HSP90-related markers, such as EGFR and AKT1,2,3, displayed alterations. The gene discussed is AKT1; the disease is colorectal cancer.